Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Teresa Palomero"'
Autor:
Agnieszka A. Wendorff, S. Aidan Quinn, Silvia Alvarez, Jessie A. Brown, Mayukh Biswas, Thomas Gunning, Teresa Palomero, Adolfo A. Ferrando
Publikováno v:
Nature Aging. 2:1008-1023
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c98fc707daebe957509953b8dc08424a
https://doi.org/10.1038/s43587-022-00304-x
https://doi.org/10.1038/s43587-022-00304-x
Autor:
Adolfo A. Ferrando, Teresa Palomero, Brent R. Stockwell, Liang Tong, Mignon L. Loh, Julie M. Gastier-Foster, Cindy Ma, Hannah I. Miller, Robert Albero, Wen-Hsuan W. Lin, Anouchka P. Laurent, Farhad Forouhar, Arie Zask, Chelsea L. Dieck, Clara Reglero
Supplementary Figure from Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b33ea786d0742501a13c41a69c7ef44
https://doi.org/10.1158/2159-8290.22542057
https://doi.org/10.1158/2159-8290.22542057
Autor:
Adolfo A. Ferrando, Teresa Palomero, Brent R. Stockwell, Liang Tong, Mignon L. Loh, Julie M. Gastier-Foster, Cindy Ma, Hannah I. Miller, Robert Albero, Wen-Hsuan W. Lin, Anouchka P. Laurent, Farhad Forouhar, Arie Zask, Chelsea L. Dieck, Clara Reglero
Low-intensity maintenance therapy with 6-mercaptopurine (6-MP) limits the occurrence of acute lymphoblastic leukemia (ALL) relapse and is central to the success of multiagent chemotherapy protocols. Activating mutations in the 5′-nucleotidase cytos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724879d7d04346e020351611ac3bd15b
https://doi.org/10.1158/2159-8290.c.6549792.v1
https://doi.org/10.1158/2159-8290.c.6549792.v1
Autor:
Adolfo A. Ferrando, Teresa Palomero, Brent R. Stockwell, Liang Tong, Mignon L. Loh, Julie M. Gastier-Foster, Cindy Ma, Hannah I. Miller, Robert Albero, Wen-Hsuan W. Lin, Anouchka P. Laurent, Farhad Forouhar, Arie Zask, Chelsea L. Dieck, Clara Reglero
Supplementary Table from Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b1347dacb24bff35508410f812e7e2
https://doi.org/10.1158/2159-8290.22542048.v1
https://doi.org/10.1158/2159-8290.22542048.v1
Autor:
Clara Reglero, Chelsea L. Dieck, Arie Zask, Farhad Forouhar, Anouchka P. Laurent, Wen-Hsuan W. Lin, Robert Albero, Hannah I. Miller, Cindy Ma, Julie M. Gastier-Foster, Mignon L. Loh, Liang Tong, Brent R. Stockwell, Teresa Palomero, Adolfo A. Ferrando
Publikováno v:
Cancer Discov
Low-intensity maintenance therapy with 6-mercaptopurine (6-MP) limits the occurrence of acute lymphoblastic leukemia (ALL) relapse and is central to the success of multiagent chemotherapy protocols. Activating mutations in the 5′-nucleotidase cytos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993ed9dee959ca6c9f9a09886a4b291b
https://europepmc.org/articles/PMC9633388/
https://europepmc.org/articles/PMC9633388/
Publikováno v:
Cancer Research. 83:3928-3928
T-cell Acute Lymphoblastic Leukemia (T-ALL) is hematologic tumor characterized by the diffuse infiltration of the bone marrow by malignant hematopoietic cells expressing immature T cell markers. Although T-ALL currently has better cure rates primaril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2fba68b3d22e8d10912f6fb08b0ef84
https://doi.org/10.1158/1538-7445.am2023-3928
https://doi.org/10.1158/1538-7445.am2023-3928
Autor:
Teresa Palomero, Megan H. Trager, Jose R. Cortes, Anisha J. Cooke, Yuhan Gu, Marta Sanchez-Martin, Adam Mackey, Larisa J. Geskin, Anouchka P. Laurent, Adolfo A. Ferrando, Christina C. Patrone, Stuart Aidan Quinn, Bobby B. Shih
Publikováno v:
J Invest Dermatol
Sezary syndrome is an aggressive and disseminated form of cutaneous T-cell lymphoma associated with dismal prognosis in which the histone deacetylase inhibitor romidepsin has shown remarkable activity as a single agent. However, clinical responses to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04753e566f3643557a050d585082909a
https://europepmc.org/articles/PMC9020801/
https://europepmc.org/articles/PMC9020801/
Autor:
Cristiana Carniti, Luca Agnelli, Annalisa Chiappella, Tayla Heavican, Daniel Leongamornlert, Pier Luigi Zinzani, Wenyi Wang, Adam Butler, Javeed Iqbal, Paolo Corradini, Francesco Zaja, Niccolo Bolli, Wing C. Chan, Antonino Neri, Anna Dodero, Alessio Pellegrinelli, Roberto Piva, Francesco Maura, Giancarlo Pruneri, Giorgio Inghirami, Alice Di Rocco, Shriram G. Bhosle, Teresa Palomero, Peter J. Campbell
Publikováno v:
American Journal of Hematology. 94:628-634
© 2019 Wiley Periodicals, Inc. The histological diagnosis of peripheral T-cell lymphoma (PTCL) can represent a challenge, particularly in the case of closely related entities such as angioimmunoblastic T-lymphoma (AITL), PTCL-not otherwise specified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8714bf0ba12ef92760256906dcede5e9
https://doi.org/10.1002/ajh.25450
https://doi.org/10.1002/ajh.25450
Autor:
Raul Rabadan, Jose R. Cortes, Adolfo A. Ferrando, Craig R. Soderquist, Teresa Palomero, Anisha J. Cooke, Clara Reglero, Silvia Alvarez, Junfei Zhao, Elias Campo, Christine S. Moon, S. Aidan Quinn, Govind Bhagat, Claudia Fiñana, Francesco Abate, Wen-Hsuan Lin, Giorgio Inghirami
Publikováno v:
Nat Cancer
Angioimmunoblastic T cell lymphoma (AITL) and peripheral T cell lymphoma not-otherwise-specified (PTCL, NOS) have poor prognosis and lack driver actionable targets for directed therapies in most cases. Here we identify FYN-TRAF3IP2 as a recurrent onc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d32508b2224c616ea6a9c3cbc326ce
https://europepmc.org/articles/PMC8081346/
https://europepmc.org/articles/PMC8081346/
Autor:
Jose R. Cortes, Ioan Filip, Robert Albero, Juan A. Patiño-Galindo, S. Aidan Quinn, Wen-Hsuan W. Lin, Anouchka P. Laurent, Bobby B. Shih, Jessie A. Brown, Anisha J. Cooke, Adam Mackey, Jonah Einson, Sakellarios Zairis, Alfredo Rivas-Delgado, Maria Antonella Laginestra, Stefano Pileri, Elias Campo, Govind Bhagat, Adolfo A. Ferrando, Raul Rabadan, Teresa Palomero
Publikováno v:
Cell Reports. 39:110695
Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) comprises heterogeneous lymphoid malignancies characterized by pleomorphic lymphocytes and variable inflammatory cell-rich tumor microenvironment. Genetic drivers in PTCL-NOS include genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4272ce238eeedfbd6858e1428e8b036
https://doi.org/10.1016/j.celrep.2022.110695
https://doi.org/10.1016/j.celrep.2022.110695